CRIS Q4 2016 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$14M

Q4 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+12.9% YoY

Gross Profit

$2M94.9% margin

Operating Income

-$11M-455.7% margin

Net Income

-$11M-479.9% margin

EPS (Diluted)

$-8.06

QoQ Revenue Growth

+34.3%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$58M

Total Liabilities

$28M

Stockholders' Equity

$29M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+12.9%
Gross Profit	$2M	$2M	+12.6%
Operating Income	-$11M	-$13M	+18.7%
Net Income	-$11M	-$13M	+15.8%

Revenue Segments

Drug Development Royalty

$1,838100%